Search research articles
Contact Us
Filters
Showing results (351-360 of 375) with videos related to
Page
of 38
Sort By:
JAMA
|
April 2, 2024
Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer
Roberto A Leon-Ferre, Sarah Flora Jonas, Roberto Salgado, et al.
Breast (Edinburgh, Scotland)
|
April 28, 2026
Real-world effectiveness of CDK4/6 inhibitors in older patients with HR+/HER2- advanced breast cancer: a sub-analysis of the multicenter, PALMARES-2 study
Francesca Ligorio, Leonardo Provenzano, Giuseppe Fotia, et al.
Nature Communications
|
June 24, 2026
Risk stratification and relapse pattern in triple-negative breast cancer with pathological complete response after neoadjuvant treatment: the European GAMBIT real-world study
Davide Massa, Theodoros Foukakis, Sylvie Giacchetti, et al.
ESMO Open
|
March 4, 2017
Career opportunities and benefits for young oncologists in the European Society for Medical Oncology (ESMO)
Gilberto Morgan, Matteo Lambertini, Hampig Raphael Kourie, et al.
JNCI Cancer Spectrum
|
May 25, 2026
Outcomes and treatment patterns in germline BRCA1/2 carriers from two matched cohort
Stefania Morganti, Se E Kim, Qingchun Jin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 17, 2020
Pregnancy After Breast Cancer in Patients With Germline <i>BRCA</i> Mutations
Matteo Lambertini, Lieveke Ameye, Anne-Sophie Hamy, et al.
Journal for Immunotherapy of Cancer
|
November 30, 2022
Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries
Alessio Cortellini, Gino M Dettorre, Urania Dafni, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 29, 2025
Assisted reproductive technology in young BRCA carriers with a pregnancy after breast cancer: An international cohort study
Isotta Martha Magaton, Eva Blondeaux, Anne-Sophie Hamy, et al.
Breast (Edinburgh, Scotland)
|
January 31, 2026
Effectiveness comparison of first-line CDK4/6 inhibitors in patients with hormone-positive HER2-negative advanced breast cancer according to tumor histology: a sub-analysis of the real-world, multicenter, Italian study PALMARES-2
Giacomo Mazzoli, Leonardo Provenzano, Maria Vittoria Dieci, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
November 29, 2023
Previous immune checkpoint inhibitor therapy is associated with decreased COVID-19-related hospitalizations and complications in patients with cancer: Results of a propensity-matched analysis of the OnCovid registry
Anahita Mostaghim, Samuel Minkove, Juan Aguilar-Company, et al.
Page
of 38
Search research articles
Search
Showing results (351-360 of 375) with videos related to
Sort By:
Page
of 38
JAMA
|
April 2, 2024
Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer
Roberto A Leon-Ferre, Sarah Flora Jonas, Roberto Salgado, et al.
Breast (Edinburgh, Scotland)
|
April 28, 2026
Real-world effectiveness of CDK4/6 inhibitors in older patients with HR+/HER2- advanced breast cancer: a sub-analysis of the multicenter, PALMARES-2 study
Francesca Ligorio, Leonardo Provenzano, Giuseppe Fotia, et al.
Nature Communications
|
June 24, 2026
Risk stratification and relapse pattern in triple-negative breast cancer with pathological complete response after neoadjuvant treatment: the European GAMBIT real-world study
Davide Massa, Theodoros Foukakis, Sylvie Giacchetti, et al.
ESMO Open
|
March 4, 2017
Career opportunities and benefits for young oncologists in the European Society for Medical Oncology (ESMO)
Gilberto Morgan, Matteo Lambertini, Hampig Raphael Kourie, et al.
JNCI Cancer Spectrum
|
May 25, 2026
Outcomes and treatment patterns in germline BRCA1/2 carriers from two matched cohort
Stefania Morganti, Se E Kim, Qingchun Jin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 17, 2020
Pregnancy After Breast Cancer in Patients With Germline <i>BRCA</i> Mutations
Matteo Lambertini, Lieveke Ameye, Anne-Sophie Hamy, et al.
Journal for Immunotherapy of Cancer
|
November 30, 2022
Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries
Alessio Cortellini, Gino M Dettorre, Urania Dafni, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 29, 2025
Assisted reproductive technology in young BRCA carriers with a pregnancy after breast cancer: An international cohort study
Isotta Martha Magaton, Eva Blondeaux, Anne-Sophie Hamy, et al.
Breast (Edinburgh, Scotland)
|
January 31, 2026
Effectiveness comparison of first-line CDK4/6 inhibitors in patients with hormone-positive HER2-negative advanced breast cancer according to tumor histology: a sub-analysis of the real-world, multicenter, Italian study PALMARES-2
Giacomo Mazzoli, Leonardo Provenzano, Maria Vittoria Dieci, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
November 29, 2023
Previous immune checkpoint inhibitor therapy is associated with decreased COVID-19-related hospitalizations and complications in patients with cancer: Results of a propensity-matched analysis of the OnCovid registry
Anahita Mostaghim, Samuel Minkove, Juan Aguilar-Company, et al.
Page
of 38